When human CD47 is immobilized at 2µg/mL (100 µL/well), the concentration for 50% of maximal effect(EC50) of ichorbio's magrolimab biosimilar is 0.075 ug/ml.

Magrolimab Biosimilar - Research Grade

(0) Write a Review
$300.00 - $5,000.00

Magrolimab Biosimilar - Research Grade manufactured in Oxford, United Kingdom. Bulk quantities of Magrolimab biosimilar in stock in UK and USA.

SKU:
ICH5036
Adding to cart… The item has been added
When human CD47 is immobilized at 2µg/mL (100 µL/well), the concentration for 50% of maximal effect(EC50) of ichorbio's magrolimab biosimilar is 0.075 ug/ml.
When human CD47 is immobilized at 2µg/mL (100 µL/well), the concentration for 50% of maximal effect(EC50) of ichorbio's magrolimab biosimilar is 0.075 ug/ml.

Similar Products

Details

Magrolimab Biosimilar - Research Grade

Product Benefits:

ichorbio’s Magrolimab Biosimilar for Research Use Only (RUO)

Target:

CD47

Size:

ichorbio’s Magrolimab Biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg, 100mg

Isotype:

Human IgG4

Host:

CHO cells

Species Reactivity:

Human

Specificity:

Detects human CD47.

Purification Method:

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Concentration:

5mg/ml

Formulation:

Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity:

>95% by SDS-PAGE

Endotoxin:

≤ 1.0 EU/mg as determined by the LAL method

Storage:

This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.

Applications:

Functional Assays

Application Notes:

This biosimilar is strictly for research use only (RUO).

Downloads

!